siRNA-mediated reduction of α-globin results in phenotypic improvements in β-thalassemic cells

Haematologica

Volumn 93, Issue 8, 2008, Pages 1238-1242

  Voon, Hsiao Phin Joanna ^a   Wardan, Hady ^a   Vadolas, Jim ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

globin; thalassemic cells; Phenotypic; siRNA mediated reduction

Indexed keywords

ALPHA GLOBIN; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; BETA THALASSEMIA; CELL CULTURE; CONTROLLED STUDY; ELECTROPORATION; ERYTHROID CELL; ERYTHROLEUKEMIA CELL; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN TARGETING; RNA SEQUENCE; WILD TYPE;

ANIMALS; BETA-THALASSEMIA; CELL DEATH; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GLOBINS; HUMANS; LEUKEMIA, ERYTHROBLASTIC, ACUTE; MICE; MICE, KNOCKOUT; PHENOTYPE; POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING;

EID: 48749098844     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.12555     Document Type: Article

References (20)

1. Weatherall D, Clegg J. The Thalassaemia Syndromes. London: Blackwell Science 2001.
2. Sorensen S, Rubin E, Polster H, Mohandas N, Schrier S. The role of membrane skeletal-associated α-globin in the pathophysiology of β-thalassemia. Blood 1990;75:1333-6.
3. Schrier SL, Mohandas N. Globinchain specificity of oxidation-induced changes in red blood cell membrane properties. Blood 1992;79:1586-92.
4. Advani R, Rubin E, Mohandas N, Schrier SL. Oxidative red blood cell membrane injury in the pathophysiology of severe mouse β-thalassemia. Blood 1992;79:1064-7.
5. Kanavakis E, Traeger-Synodinos J, Lafioniatis S, Lazaropoulou C, Liakopoulou T, Paleologos G, et al. A rare example that coinheritance of a severe form of β-thalassemia and alpha-thalassemia interact in a "synergistic" manner to balance the phenotype of classic thalassemic syndromes. Blood Cells Mol Dis 2004;32:319-24.
6. Kulozik AE, Kohne E, Kleihauer E. Thalassemia intermedia: compound heterozygous β zero/β(+)-thalassemia and co-inherited heterozygous α(+)-thalassemia. Ann Hematol 1993;66:51-4.
7. Galanello R, Dessi E, Melis MA, Addis M, Sanna MA, Rosatelli C, et al. Molecular analysis of β0-thalassemia intermedia in Sardinia. Blood 1989;74:823-7.
8. Thein SL. Genetic modifiers of β-thalassemia. Haematologica 2005;90:649-60.
9. Detloff PJ, Lewis J, John SW, Shehee WR, Langenbach R, Maeda N, et al. Deletion and replacement of the mouse adult β-globin genes by a "plug and socket" repeated targeting strategy. Mol Cell Biol 1994;14:6936-43.
10. Scher BM, Scher W, Robinson A, Waxman S. DNA ligase and DNase activities in mouse erythroleukemia cells during dimethyl sulfoxide-induced differentiation. Cancer Res 1982;42:1300-6.
11. von Lindern M, Deiner EM, Dolznig H, Parren-Van Amelsvoort M, Hayman MJ, et al. Leukemic transformation of normal murine erythroid progenitors: v- and c-ErbB act through signaling pathways activated by the EpoR and c-Kit in stress erythropoiesis. Oncogene 2001;20:3651-64.
12. Amer J, Goldfarb A, Fibach E. Flow cytometric measurement of reactive oxygen species production by normal and thalassaemic red blood cells. Eur J Haematol 2003;70:84-90.
13. Paszty C, Mohandas N, Stevens ME, Loring JF, Liebhaber SA, Brion CM, et al. Lethal α-thalassaemia created by gene targeting in mice and its genetic rescue. Nat Genet 1995;11:33-9.
14. Voon HP, Wardan H, Vadolas J. Coinheritance of α- and β-thalassaemia in mice ameliorates thalassaemic phenotype. Blood Cells Mol Dis 2007;39:184-8.
15. Lewis DL, Hagstrom JE, Loomis AG, Wolff JA, Herweijer H. Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat Genet 2002;32:107-8.
16. Mottet-Osman G, Iseni F, Pelet T, Wiznerowicz M, Garcin D, Roux L. Suppression of the Sendai virus M protein through a novel short interfering RNA approach inhibits viral particle production but does not affect viral RNA synthesis. J Virol 2007;81:2861-8.
17. Xie SY, Ren ZR, Zhang JZ, Guo XB, Wang QX, Wang S, et al. Restoration of the balanced {α}/{β}-globin gene expression in {β}654- thalassemia mice using combined RNAi and antisense RNA approach. Hum Mol Genet 2007;16:2616-25.
18. Zeng Y, Cullen BR. RNA interference in human cells is restricted to the cytoplasm. RNA 2002;8:855-60.
19. Banks GA, Roselli RJ, Chen R, Giorgio TD. A model for the analysis of nonviral gene therapy. Gene Ther 2003;10:1766-75.
20. Howden SE, Wardan H, Voullaire L, McLenachan S, Williamson R, Ioannou P, et al. Chromatin-binding regions of EBNA1 protein facilitate the enhanced transfection of Epstein-Barr virus-based vectors. Hum Gene Ther 2006;17:833-44.